Medica Corp

MA - BedfordDiagnostics3 H-1B visas (FY2023)

Focus: Medica Corp is a diagnostics-focused company specializing in in-vitro diagnostic analyzers, founded in 1983 and headquartered in Bedford, MA. The company generates revenue primarily from branded and generic therapeutics across oncology, cardiovascular, neurology, immunology, and hematology.

Oncology Cardiovascular Neurology Immunology

Profile data last refreshed 37m ago · AI intelligence enriched 1w ago

Open Jobs

4 recent layoff filings (12 mo) — 196 affected

1/30/2026 — San Diego, CA · 83 affected · Layoff Permanent
1/7/2026 — Pomona, CA · 108 affected · Layoff Permanent
1/7/2026 — Claremont, CA · 1 affected · Layoff Permanent
+1 more

Source: state DOL filings via Big Local News

Should You Work at Medica Corp?

AI assessment

Medica Corp offers stability in diagnostics and established commercial revenue, but ongoing layoffs and a thin early-stage pipeline present medium-term career risk; best suited for operationally-focused roles in supply chain or clinical affairs willing to navigate restructuring.

Why Work Here

Diversified product portfolio across five therapeutic areas with established revenue streams, including peak-stage drug TYRVAYA generating $37M in Part D spending

Data completeness

4/9 — Basic

Company HealthSolid

Pipeline

Early-stage

50 total

LOE Risk

1 in 5yr

ZIPSOR

Hiring

Stable

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Key Products

TYRVAYA

Not specified

$37M

Peak9.1yr

Peak-stage branded asset accounting for 33% of company revenue; exclusivity extends to 2035.

Help build intelligence for Medica Corp

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

H1B sponsorship track record: 3 approvals and 0 denials in 2023 suggests openness to international talent

Currently hiring across supply chain (3 roles), clinical (2 roles), and IT (1 role) with active growth in operational infrastructure

Watch Out For

Significant restructuring headwinds: 600+ employees laid off or affected across six WARN Act filings between Aug 2025–Jan 2026, including permanent facility closures in Willows CA (225 employees) and Herndon VA (162 employees)
Heavily dependent on generic and post-LOE assets; only 1 pre-launch program (Dimethyl Fumarate) with minimal early-stage pipeline momentum (3 Phase 1, 2 Phase 2 programs out of 30 total)
Patent cliff risk emerging: ZIPSOR loses exclusivity Feb 2029, and TYRVAYA (33% of revenue) faces LOE in Oct 2035

Generated by Claude from Medica Corp's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

IMATINIB MESYLATE

CML/GIST (protein-tyrosine kinase inhibitor)

$36M

Post-LOE

Post-LOE generic generating $36M Part D spending; second-largest revenue contributor.

IMATINIB MESYLATE

CML/GIST (protein-tyrosine kinase inhibitor)

$21M

Post-LOE

Additional ANDA formulation of imatinib generating $21M in Part D spending.

DIMETHYL FUMARATE

Relapsing forms of multiple sclerosis (MS)

$14M

Pre-Launch

Pre-launch ANDA for DMF in relapsing MS; represents early pipeline maturation.

CAMBIA

Pain/migraine (NSAID)

$2M

Post-LOEPost-LOE

Post-LOE branded NSAID with LOE approaching mid-2026; minimal revenue contribution.

CHLORTHALIDONE

Hypertension management

$1M

Post-LOE

Post-LOE generic diuretic generating minimal revenue; mature market asset.

ZIPSOR

Pain/migraine (NSAID)

$797K

LOE Approaching2.4yr

LOE approaching Feb 2029; represents $797K at-risk revenue in nearest cliff.

DOCETAXEL

Metastatic breast cancer, metastatic NSCLC

$699K

Post-LOE

Post-LOE generic chemotherapy generating minimal revenue.

DICLOFENAC POTASSIUM TABLETS

Rheumatoid arthritis, primary dysmenorrhea

$690K

Post-LOE

Post-LOE generic NSAID with low market share.

DICLOFENAC POTASSIUM

Migraine (NSAID)

$690K

Post-LOE

Post-LOE generic NSAID formulation with minimal revenue.

Pipeline & Clinical Trials

antiviral therapies for CMV and/or ADV

Infectious Complications Following HSCT

N/A

Clinical Trials (1)

NCT02873325Registry on Salvage Antiviral Treatment for Patients Experiencing ADV and / or CMV Reactivation Post Allogeneic HSCT

N/A

Striatin

Malnourished Children

N/A

Clinical Trials (1)

NCT06933862Effects of Channa Striata Extract on Intestinal Inflammation and Nutritional Status in Malnutritional Toddlers After Albendazole Therapy in South Bangka District

N/A

Symptomatology, Treatment. daily Activities and Anxiety for Cardiovascular patients Survey

Cardiovascular Diseases

N/A

Clinical Trials (1)

NCT04508920A Survey to Assess Effects of Covid-19 on Cardiovascular Patients

N/A

HIBA-Institutional Registry of Amyloidosis

Amyloidosis

N/A

Clinical Trials (1)

NCT01347047HIBA-Institutional Registry of Amyloidosis

N/A

Surgery with FACET FIXATION implants

Degenerative Lumbar Spinal Stenosis

N/A

Clinical Trials (1)

NCT05645497Evaluation of the Efficacy and Safety of the FACET FIXation Implant.

N/A

magnetic facial nerve stimulation

Normal Subject / Healthy Volunteers

N/A

Clinical Trials (1)

NCT03487393VitalFlow Healthy Volunteer Study

N/A

Use of Molecular Breast Imaging (MBI) to Detect Additional Disease in Women With Breast Cancer Who A

Breast Cancer

N/A

Clinical Trials (1)

NCT00776308Use of Molecular Breast Imaging (MBI) to Detect Additional Disease in Women With Breast Cancer Who Are About to go to Surgery

N/A

Rotational fractional resection

Skin Laxity

N/A

Clinical Trials (1)

NCT03407313CONFORM: Rotational Fractional Resection for Submental Contouring

N/A

Glimepiride

Chronic Heart Failure

N/A

Clinical Trials (1)

NCT05538819The Effects of Glimepiride in Patients With Type 2 Diabetes and Chronic Heart Failure

N/A

Screening in Myocardial Perfusion Patients

Breast Cancer

N/A

Clinical Trials (1)

NCT00943241Screening in Myocardial Perfusion Patients

N/A

ChitoCare® medical Wound Healing Gel

Dermatitis

N/A

Clinical Trials (1)

NCT06850389PMCF Investigation of Medical Device ChitoCare® Medical

N/A

Nasal swab

Inflammation

N/A

Clinical Trials (1)

NCT03311048Airway Inflammatory Profile Among Cleaning Workers From Different Workplaces

N/A

Upadacitinib

Atopic Dermatitis

N/A

Clinical Trials (1)

NCT05989932Real-world Experience on the Use of Upadacitinib in the Treatment of Moderate-severe Adult Atopic Dermatitis (ERUDA)

N/A

CeraVe Moisturizing Cream

Atopic Dermatitis (AD)

N/A

Clinical Trials (1)

NCT07204561CeraVe Effect on Restoring Skin Hydration as Maintenance Regimen in Subjects With Mild to Moderate Atopic Dermatitis

N/A

Motilis-3D-transit

Ulcerative Colitis

N/A

Clinical Trials (1)

NCT01745029Gastrointestinal Motility in Severe Ulcerative Colitis Obtained by Motilis-3D-transit

N/A

Nutritional counseling

Overweight

N/A

Clinical Trials (1)

NCT02887950Resistant Starch, Epigallocatechin Gallate and Chlorogenic Acid for Body Weight Loss in Menopause

N/A

Motilis-3D transit

Ulcerative Colitis

N/A

Clinical Trials (1)

NCT01752361Gastrointestinal Transit Times and Motility in Severe Ulcerative Colitis Obtained by Motilis-3D-transit

N/A

Treatment A

Perennial Allergic Rhinitis

N/A

Clinical Trials (1)

NCT05122143Efficacy and Safety of AM-301 on Allergic Symptoms of Perennial Allergic Rhinitis Sufferers

N/A

Non-pharmacological approach of insomnia

Insomnia

N/A

Clinical Trials (1)

NCT01091987Non-pharmacological Treatment of Insomnia in Nursing Homes.

N/A

Hydrocortisone

Healthcare-Associated Pneumonia

N/A

Clinical Trials (1)

NCT05354778HYDROcortisone Versus Placebo for Severe HospItal-acquired Pneumonia in Intensive Care Patients: the HYDRO-SHIP Study

N/A

Computed Tomography Coronary Angiography (CTCA) Prognostic Registry for Coronary Artery Disease

Coronary Artery Disease

N/A

Clinical Trials (1)

NCT01384721Computed Tomography Coronary Angiography (CTCA) Prognostic Registry for Coronary Artery Disease

N/A

Quikclot Radial

Coronary Artery Disease

N/A

Clinical Trials (1)

NCT03535597Hemostasis With QuikClot® Radial® Pad Versus TR Band® After Transradial Artery Access

N/A

Perindopril 4 mg tablets of PT Dexa Medica

Healthy

N/A

Clinical Trials (1)

NCT01682577Bioequivalence Study of Two Formulations of Perindopril 4 mg Tablet Under Fasting Condition

N/A

Retrospective and Prospective Observational Study in Patients With Advanced Basal Cell Carcinoma

Basal Cell Carcinoma

N/A

Clinical Trials (1)

NCT06309836Retrospective and Prospective Observational Study in Patients With Advanced Basal Cell Carcinoma

N/A

Mirabilis System

Uterine Leiomyoma

N/A

Clinical Trials (1)

NCT03219385Directed Ablation of Uterine Fibroids Using a Noninvasive Approach

N/A

Individualized educational program

Asthma

N/A

Clinical Trials (1)

NCT03655392Clinical, Functional and Inflammatory Evaluation in Asthmatic Patients After a Simple Short-Term Educational Program

N/A

Dapagliflozin 10 mg film-coated tablet

Healthy

N/A

Clinical Trials (1)

NCT06127212Bioequivalence Study of Dapagliflozin 10 mg Film-coated Tablets

N/A

Glucose and lipids

Hyperlipidemia

N/A

Clinical Trials (1)

NCT02029989Point-of-Care Testing (POCT) Detection and Management of Metabolic Syndrome in Patients With Mental Illness

N/A

colonoscopy

Inflammatory Bowel Diseases

N/A

Clinical Trials (1)

NCT05576402Endoscopic Scoring System Utilization in Inflammatory Bowel Disease

N/A

Cardiac Contractility Modulation

Chagas Cardiomyopathy

N/A

Clinical Trials (1)

NCT05519046Cardiac Contractility Modulation in Chagas Heart Disease

N/A

Valsartan 160 mg film-coated caplets

Healthy

N/A

Clinical Trials (1)

NCT02518451Bioequivalence Evaluation of Two Film-Coated Formulations of Valsartan 160 mg

N/A

topical treatment with the pre- and postbiotic study preparation and niacinamide 4% and one with the 10% urea-based preparation.

Xerosis Cutis

N/A

Clinical Trials (1)

NCT06868771Study on the Effectiveness of an Emollient Cream Containing Pre and Postbiotic and Niacinamide 4% in the Treatment of Skin Xerosis and Itching in Oncological Patients Treated with Anti-EGFR

N/A

Hormonal Effects on Tc-99m Sestamibi Uptake in the Breast

Breast Cancer

N/A

Clinical Trials (1)

NCT00943527Hormonal Effects on Tc-99m Sestamibi Uptake in the Breast

N/A

National Register of Moderate and Severe Adult Atopic Dermatitis

Atopic Dermatitis

N/A

Clinical Trials (1)

NCT06313333National Register of Moderate and Severe Adult Atopic Dermatitis

N/A

Focal Contouring System

Skin Laxity

N/A

Clinical Trials (1)

NCT03853980The INFORM Study: Rotational Fractional Resection for Submental Contouring

N/A

quadrivalent subunit influenza vaccine

Influenza Vaccine

N/A

Low calorie diet treatment

Infertility

N/A

Clinical Trials (1)

NCT01566929Weight Management Intervention for Obese Women and the Live Birth Outcome of in Vitro Fertilization (IVF)

N/A

Point of Care - Glycated Hemoglobin

Diabetes Mellitus, Type 2

N/A

Clinical Trials (1)

NCT05440968Comparative Effectiveness of POC-A1c vs the Current Standard Based on OGTT for Early Detection DM2 in Colombia

N/A

Mirabilis High-Intensity Focused Ultrasound Treatment System

Uterine Fibroids (Leiomyomas)

N/A

Clinical Trials (1)

NCT01946178Clinical Study of the Mirabilis High-Intensity Focused Ultrasound System for Non-Invasive Treatment of Uterine Fibroids

N/A

Rotational fractional resection

Skin Laxity

N/A

Clinical Trials (1)

NCT03966924The PREFORM Study: Rotational Fractional Resection for Submental Contouring

N/A

500 mg metformin hydrochloride extended release caplet

Metformin XR BE Study in Healthy Volunteers With Single and Multiple Dose

N/A

Clinical Trials (1)

NCT01677260Bioequivalence Study of Two Formulations of 500 mg Metformin Extended Release Tablet

N/A

Pregabalin capsules 150 mg of Dexa Medica

Healthy

N/A

Clinical Trials (1)

NCT02233777Bioequivalence Study of Two Formulations of Pregabalin Capsules 150 mg

N/A

no interventions

Short Bowel Syndrome

N/A

Clinical Trials (1)

NCT04976075ImpRovE underSTanding of Short bOwel syndRome in Latin-amErica

N/A

Surgery

Breast Cancer

N/A

Clinical Trials (1)

NCT06447532Use of Machine Learning Techniques for Serial Assessment of Systemic Inflammatory Markers in Breast Cancer Patients

N/A

18F-

Lung Cancer

N/A

Clinical Trials (1)

NCT035687994-[18F]Fluoroglutamine PET/CT in Imaging Patients With Newly Diagnosed Lung Cancer or Indeterminate Pulmonary Nodules

N/A

Liquid Chromatography-Mass Spectrometry Method to identify bilirubin molecular species

Hepatic Encephalopathy

N/A

Clinical Trials (1)

NCT05566548Role of Bilirubin Molecular Species in Hepatic Encephalopathy and Acute-on-chronic Liver Failure

N/A

ClorNovir®

COVID-19

N/A

Clinical Trials (1)

NCT05520944Accelerating COVID-19 Clinical Recovery in the Outpatient Setting: Retrospective Analysis

N/A

cyclamax

Insomnia

N/A

Clinical Trials (1)

NCT00484497Evaluation of a Food Supplement on Sleep Quality

N/A

Lisinopril 10 mg tablets of PT Dexa Medica

Healthy

N/A

Clinical Trials (1)

NCT01936012Bioequivalence Study of Two Formulations of 10 mg Lisinopril Tablet Under Fasting Condition

N/A

data collection

Scabies

N/A

Clinical Trials (1)

NCT07305961National Study on the Epidemiology and Effectiveness of Therapies in the Treatment of Scabies

N/A

Interview Prep Quick Facts

Founded: 1983

Portfolio: 207 approved products, 149 clinical trials

Top TAs: Cardiovascular, Oncology, Respiratory

H-1B (2023): 3 approvals

Open Roles: 7 active jobs

Portfolio Health

Pre-Launch34 (16%)

Launch1 (0%)

Growth1 (0%)

Peak6 (3%)

LOE Approaching25 (12%)

Post-LOE140

Therapeutic Area Focus

Cardiovascular

44 marketed17 pipeline

Oncology

35 marketed23 pipeline

Respiratory

32 marketed21 pipeline

Neurology

30 marketed12 pipeline

Hiring Trend

Stable

Open Roles

Added

-0

Filled/Removed

Based on last 4 crawl cycles

Visa Sponsorship

Sponsors Work Visas

H-1B Petitions (FY2023)

Approved

Denied

100%

Rate

Source: USCIS H-1B Employer Data Hub

Risk Signals

WARN Act Layoff Notices (6)

2026-01-30

83 employees affected— San Diego, CA

2026-01-07

108 employees affected— Pomona, CA

2026-01-07

1 employees affected— Claremont, CA

2026-01-07

4 employees affected— Pomona, CA

INTRAVENOUS · INJECTABLE

Radiopharmaceutical Activity

16 marketed18 pipeline

Metabolic Diseases

8 marketed19 pipeline

Immunology

16 marketed6 pipeline

Women's Health

2 marketed9 pipeline

225 employees affected— Willows, CA

2025-03-31

162 employees affected— Herndon VA, VA

Source: state DOL filings, aggregated via Big Local News

1 active drug shortage

583 employees affected across six WARN Act filings from Aug 2025–Jan 2026, including permanent facility closure in Willows CA (225 employees) and Herndon VA (162 employees).

Significant structural headcount reduction signals urgent cost pressures and likely continued restructuring; very high career risk for non-core or cyclical roles.

Pro Feature

Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.

Upgrade to Pro — $25/mo

Medica Corp

Should You Work at Medica Corp?

Why Work Here

Key Products

Watch Out For

Products & Portfolio (60)

Key Products by Revenue

Other Products (53)

Pipeline & Clinical Trials

Open Jobs (7)

Senior Sonographer – Women's Health & Obstetric Ultrasound Development Programme

Senior Radiographer

Radiology Assistant (18 hours per week)

Service Desk Engineer

Candidate Advanced Practitioner (cAP) Sonographer – North Dublin

Part-time Radiographer

Candidate Advanced Practitioner (cAP) Sonographer – South Dublin & South East

Hiring Trend

Visa Sponsorship

Risk Signals

WARN Act Layoff Notices (6)